Hotline: +86-18022463983    020-85206863

Global Biologic and Medical Imaging Reagents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: 2025-06-23   |   Pages: 142   |   Tables: 140   |  Medical Devices & Consumables

In 2024, the global market size of Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million and is forecast to reach approximately US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biologic and Medical Imaging Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic and Medical Imaging Reagents.
The Biologic and Medical Imaging Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic and Medical Imaging Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic and Medical Imaging Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG
Segment by Type
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biologic and Medical Imaging Reagents in global and regional level.
Chapter 3: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic and Medical Imaging Reagents revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Study Coverage
1.1 Biologic and Medical Imaging Reagents Product Introduction
1.2 Market by Type
1.2.1 Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Nuclear Imaging (PET & SPECT) Reagents
1.2.3 Magnetic Resonance Imaging (MRI) Reagents
1.2.4 Fluorescence Imaging Reagents
1.2.5 Ultrasound and X-ray Contrast Reagents
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologic and Medical Imaging Reagents Market Size Estimates and Forecasts
2.2 Biologic and Medical Imaging Reagents Market Size by Region: 2024 Versus 2031
2.2.1 Global Biologic and Medical Imaging Reagents Revenue by Region: 2020-2025
2.2.2 Global Biologic and Medical Imaging Reagents Revenue Forecast by Region (2026-2031)
2.2.3 Global Biologic and Medical Imaging Reagents Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biologic and Medical Imaging Reagents Revenue by Type (2020-2031)
3.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biologic and Medical Imaging Reagents Revenue by Application (2020-2031)
3.2.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Nuclear Imaging (PET & SPECT) Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application
3.3.2 Magnetic Resonance Imaging (MRI) Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application
3.3.3 Fluorescence Imaging Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application
3.3.4 Ultrasound and X-ray Contrast Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application
3.3.5 Other of Biologic and Medical Imaging Reagents Revenue Market Share by Application
4 Global Biologic and Medical Imaging Reagents by Company
4.1 Global Biologic and Medical Imaging Reagents Revenue by Company (2020-2025)
4.2 Global Biologic and Medical Imaging Reagents Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biologic and Medical Imaging Reagents Companies around the World: Ranking by Revenue
4.3.2 Global Biologic and Medical Imaging Reagents Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biologic and Medical Imaging Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biologic and Medical Imaging Reagents Companies Headquarters & Product Type
4.4.1 Global Biologic and Medical Imaging Reagents Companies Headquarters
4.4.2 Date of International Companies Enter into Biologic and Medical Imaging Reagents Market
4.4.3 Global Biologic and Medical Imaging Reagents Companies Product & Service
4.4.4 Nuclear Imaging (PET & SPECT) Reagents Revenue Market Share of Biologic and Medical Imaging Reagents by Company
4.4.5 Magnetic Resonance Imaging (MRI) Reagents Revenue Market Share of Biologic and Medical Imaging Reagents by Company
4.4.6 Fluorescence Imaging Reagents Revenue Market Share of Biologic and Medical Imaging Reagents by Company
4.4.7 Ultrasound and X-ray Contrast Reagents Revenue Market Share of Biologic and Medical Imaging Reagents by Company
4.4.8 Other Revenue Market Share of Biologic and Medical Imaging Reagents by Company
4.5 Global Biologic and Medical Imaging Reagents Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Corporation Information
5.1.2 Cardinal Health Description, Business Overview
5.1.3 Cardinal Health Biologic and Medical Imaging Reagents Products Offered
5.1.4 Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.1.5 Cardinal Health Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.1.6 Cardinal Health Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.1.7 Cardinal Health Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.1.8 Cardinal Health Recent Developments
5.2 Bracco
5.2.1 Bracco Corporation Information
5.2.2 Bracco Description, Business Overview
5.2.3 Bracco Biologic and Medical Imaging Reagents Products Offered
5.2.4 Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.2.5 Bracco Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.2.6 Bracco Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.2.7 Bracco Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.2.8 Bracco Recent Developments
5.3 Bayer HealthCare
5.3.1 Bayer HealthCare Corporation Information
5.3.2 Bayer HealthCare Description, Business Overview
5.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Products Offered
5.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.3.5 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.3.6 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.3.7 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.3.8 Bayer HealthCare Recent Developments
5.4 Curium Pharma
5.4.1 Curium Pharma Corporation Information
5.4.2 Curium Pharma Description, Business Overview
5.4.3 Curium Pharma Biologic and Medical Imaging Reagents Products Offered
5.4.4 Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.4.5 Curium Pharma Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.4.6 Curium Pharma Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.4.7 Curium Pharma Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.4.8 Curium Pharma Recent Developments
5.5 Hengrui Medicine
5.5.1 Hengrui Medicine Corporation Information
5.5.2 Hengrui Medicine Description, Business Overview
5.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Products Offered
5.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.5.5 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.5.6 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.5.7 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.5.8 Hengrui Medicine Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Corporation Information
5.6.2 GE Healthcare Description, Business Overview
5.6.3 GE Healthcare Biologic and Medical Imaging Reagents Products Offered
5.6.4 GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.6.5 GE Healthcare Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.6.6 GE Healthcare Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.6.7 GE Healthcare Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.6.8 GE Healthcare Recent Developments
5.7 Lantheus Medical Imaging
5.7.1 Lantheus Medical Imaging Corporation Information
5.7.2 Lantheus Medical Imaging Description, Business Overview
5.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Products Offered
5.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.7.5 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.7.6 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.7.7 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.7.8 Lantheus Medical Imaging Recent Developments
5.8 Novartis (AAA)
5.8.1 Novartis (AAA) Corporation Information
5.8.2 Novartis (AAA) Description, Business Overview
5.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Products Offered
5.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.8.5 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.8.6 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.8.7 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.8.8 Novartis (AAA) Recent Developments
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Corporation Information
5.9.2 Thermo Fisher Scientific Description, Business Overview
5.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Products Offered
5.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.9.5 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.9.6 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.9.7 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.9.8 Thermo Fisher Scientific Recent Developments
5.10 Jubilant DraxImage
5.10.1 Jubilant DraxImage Corporation Information
5.10.2 Jubilant DraxImage Description, Business Overview
5.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Products Offered
5.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.10.5 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.10.6 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.10.7 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.10.8 Jubilant DraxImage Recent Developments
5.11 PerkinElmer
5.11.1 PerkinElmer Corporation Information
5.11.2 PerkinElmer Description, Business Overview
5.11.3 PerkinElmer Biologic and Medical Imaging Reagents Products Offered
5.11.4 PerkinElmer Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.11.5 PerkinElmer Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.11.6 PerkinElmer Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.11.7 PerkinElmer Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.11.8 PerkinElmer Recent Developments
5.12 Guerbet
5.12.1 Guerbet Corporation Information
5.12.2 Guerbet Description, Business Overview
5.12.3 Guerbet Biologic and Medical Imaging Reagents Products Offered
5.12.4 Guerbet Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.12.5 Guerbet Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.12.6 Guerbet Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.12.7 Guerbet Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.12.8 Guerbet Recent Developments
5.13 Nihon Medi-Physics
5.13.1 Nihon Medi-Physics Corporation Information
5.13.2 Nihon Medi-Physics Description, Business Overview
5.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Products Offered
5.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.13.5 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.13.6 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.13.7 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.13.8 Nihon Medi-Physics Recent Developments
5.14 YRPG
5.14.1 YRPG Corporation Information
5.14.2 YRPG Description, Business Overview
5.14.3 YRPG Biologic and Medical Imaging Reagents Products Offered
5.14.4 YRPG Biologic and Medical Imaging Reagents Revenue and Gross Margin (2020-2025)
5.14.5 YRPG Biologic and Medical Imaging Reagents Revenue by Product in 2024
5.14.6 YRPG Biologic and Medical Imaging Reagents Revenue by Application in 2024
5.14.7 YRPG Biologic and Medical Imaging Reagents Revenue by Geographic Area in 2024
5.14.8 YRPG Recent Developments
6 North America
6.1 North America Biologic and Medical Imaging Reagents Market Size YoY Growth 2020-2031
6.2 North America Biologic and Medical Imaging Reagents Market Facts & Figures by Country (2020-2031)
6.3 North America Biologic and Medical Imaging Reagents Revenue by Type (2020-2025)
6.4 North America Biologic and Medical Imaging Reagents Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biologic and Medical Imaging Reagents Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biologic and Medical Imaging Reagents Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Type (2020-2025)
7.4 Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biologic and Medical Imaging Reagents Market Size YoY Growth 2020-2031
8.2 Europe Biologic and Medical Imaging Reagents Market Facts & Figures by Country (2020-2031)
8.3 Europe Biologic and Medical Imaging Reagents Revenue by Type (2020-2025)
8.4 Europe Biologic and Medical Imaging Reagents Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biologic and Medical Imaging Reagents Market Size YoY Growth 2020-2031
9.2 Latin America Biologic and Medical Imaging Reagents Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biologic and Medical Imaging Reagents Revenue by Type (2020-2025)
9.4 Latin America Biologic and Medical Imaging Reagents Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biologic and Medical Imaging Reagents Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biologic and Medical Imaging Reagents Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Type (2020-2025)
10.4 Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biologic and Medical Imaging Reagents Supply Chain Analysis
11.2 Biologic and Medical Imaging Reagents Key Raw Materials and Upstream Suppliers
11.3 Biologic and Medical Imaging Reagents Clients Analysis
11.4 Biologic and Medical Imaging Reagents Sales Channel and Sales Model Analysis
11.4.1 Biologic and Medical Imaging Reagents Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biologic and Medical Imaging Reagents Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biologic and Medical Imaging Reagents Distributors
12 Biologic and Medical Imaging Reagents Market Dynamics
12.1 Biologic and Medical Imaging Reagents Industry Trends
12.2 Biologic and Medical Imaging Reagents Market Drivers
12.3 Biologic and Medical Imaging Reagents Market Challenges
12.4 Biologic and Medical Imaging Reagents Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Biologic and Medical Imaging Reagents Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biologic and Medical Imaging Reagents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biologic and Medical Imaging Reagents Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biologic and Medical Imaging Reagents Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologic and Medical Imaging Reagents Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biologic and Medical Imaging Reagents Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biologic and Medical Imaging Reagents Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biologic and Medical Imaging Reagents Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biologic and Medical Imaging Reagents Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biologic and Medical Imaging Reagents Players by Revenue (US$ Million) in 2024
Table 13. Global Biologic and Medical Imaging Reagents Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biologic and Medical Imaging Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic and Medical Imaging Reagents as of 2024)
Table 15. Global Biologic and Medical Imaging Reagents Companies Headquarters
Table 16. Date of International Companies Enter into Biologic and Medical Imaging Reagents Market
Table 17. Global Biologic and Medical Imaging Reagents Companies Product & Service
Table 18. Global Biologic and Medical Imaging Reagents Mergers & Acquisitions, Expansion Plans
Table 19. Cardinal Health Corporation Information
Table 20. Cardinal Health Description and Business Overview
Table 21. Cardinal Health Biologic and Medical Imaging Reagents Product
Table 22. Cardinal Health Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Cardinal Health Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 24. Cardinal Health Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 25. Cardinal Health Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 26. Cardinal Health Recent Developments
Table 27. Bracco Corporation Information
Table 28. Bracco Description and Business Overview
Table 29. Bracco Biologic and Medical Imaging Reagents Product
Table 30. Bracco Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Bracco Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 32. Bracco Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 33. Bracco Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 34. Bracco Recent Developments
Table 35. Bayer HealthCare Corporation Information
Table 36. Bayer HealthCare Description and Business Overview
Table 37. Bayer HealthCare Biologic and Medical Imaging Reagents Product
Table 38. Bayer HealthCare Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Bayer HealthCare Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 40. Bayer HealthCare Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 41. Bayer HealthCare Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 42. Bayer HealthCare Recent Developments
Table 43. Curium Pharma Corporation Information
Table 44. Curium Pharma Description and Business Overview
Table 45. Curium Pharma Biologic and Medical Imaging Reagents Product
Table 46. Curium Pharma Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Curium Pharma Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 48. Curium Pharma Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 49. Curium Pharma Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 50. Curium Pharma Recent Developments
Table 51. Hengrui Medicine Corporation Information
Table 52. Hengrui Medicine Description and Business Overview
Table 53. Hengrui Medicine Biologic and Medical Imaging Reagents Product
Table 54. Hengrui Medicine Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Hengrui Medicine Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 56. Hengrui Medicine Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 57. Hengrui Medicine Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 58. Hengrui Medicine Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Business Overview
Table 61. GE Healthcare Biologic and Medical Imaging Reagents Product
Table 62. GE Healthcare Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. GE Healthcare Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 64. GE Healthcare Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 65. GE Healthcare Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 66. GE Healthcare Recent Developments
Table 67. Lantheus Medical Imaging Corporation Information
Table 68. Lantheus Medical Imaging Description and Business Overview
Table 69. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product
Table 70. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Lantheus Medical Imaging Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 72. Lantheus Medical Imaging Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 73. Lantheus Medical Imaging Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 74. Lantheus Medical Imaging Recent Developments
Table 75. Novartis (AAA) Corporation Information
Table 76. Novartis (AAA) Description and Business Overview
Table 77. Novartis (AAA) Biologic and Medical Imaging Reagents Product
Table 78. Novartis (AAA) Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Novartis (AAA) Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 80. Novartis (AAA) Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 81. Novartis (AAA) Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 82. Novartis (AAA) Recent Developments
Table 83. Thermo Fisher Scientific Corporation Information
Table 84. Thermo Fisher Scientific Description and Business Overview
Table 85. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product
Table 86. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Thermo Fisher Scientific Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 88. Thermo Fisher Scientific Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 89. Thermo Fisher Scientific Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 90. Thermo Fisher Scientific Recent Developments
Table 91. Jubilant DraxImage Corporation Information
Table 92. Jubilant DraxImage Description and Business Overview
Table 93. Jubilant DraxImage Biologic and Medical Imaging Reagents Product
Table 94. Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Jubilant DraxImage Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 96. Jubilant DraxImage Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 97. Jubilant DraxImage Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 98. Jubilant DraxImage Recent Developments
Table 99. PerkinElmer Corporation Information
Table 100. PerkinElmer Description and Business Overview
Table 101. PerkinElmer Biologic and Medical Imaging Reagents Product
Table 102. PerkinElmer Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. PerkinElmer Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 104. PerkinElmer Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 105. PerkinElmer Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 106. PerkinElmer Recent Developments
Table 107. Guerbet Corporation Information
Table 108. Guerbet Description and Business Overview
Table 109. Guerbet Biologic and Medical Imaging Reagents Product
Table 110. Guerbet Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Guerbet Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 112. Guerbet Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 113. Guerbet Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 114. Guerbet Recent Developments
Table 115. Nihon Medi-Physics Corporation Information
Table 116. Nihon Medi-Physics Description and Business Overview
Table 117. Nihon Medi-Physics Biologic and Medical Imaging Reagents Product
Table 118. Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Nihon Medi-Physics Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 120. Nihon Medi-Physics Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 121. Nihon Medi-Physics Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 122. Nihon Medi-Physics Recent Developments
Table 123. YRPG Corporation Information
Table 124. YRPG Description and Business Overview
Table 125. YRPG Biologic and Medical Imaging Reagents Product
Table 126. YRPG Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. YRPG Revenue Proportion of Biologic and Medical Imaging Reagents by Product in 2024
Table 128. YRPG Revenue Proportion of Biologic and Medical Imaging Reagents by Application in 2024
Table 129. YRPG Revenue Proportion of Biologic and Medical Imaging Reagents by Geographic Area in 2024
Table 130. YRPG Recent Developments
Table 131. North America Biologic and Medical Imaging Reagents Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Biologic and Medical Imaging Reagents Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Biologic and Medical Imaging Reagents Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Biologic and Medical Imaging Reagents Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Biologic and Medical Imaging Reagents Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Biologic and Medical Imaging Reagents Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Biologic and Medical Imaging Reagents Revenue by Application (2020-2025) & (US$ Million)
Table 151. Biologic and Medical Imaging Reagents Key Raw Materials, Industry Status and Trend
Table 152. Biologic and Medical Imaging Reagents Key Raw Materials and Upstream Suppliers
Table 153. Biologic and Medical Imaging Reagents Clients Status and Trend
Table 154. Biologic and Medical Imaging Reagents Typical Clients
Table 155. Biologic and Medical Imaging Reagents Distributors
Table 156. Biologic and Medical Imaging Reagents Market Trends
Table 157. Biologic and Medical Imaging Reagents Market Drivers
Table 158. Biologic and Medical Imaging Reagents Market Challenges
Table 159. Biologic and Medical Imaging Reagents Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources


List of Figures
Figure 1. Biologic and Medical Imaging Reagents Product Picture
Figure 2. Global Biologic and Medical Imaging Reagents Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type in 2024 & 2031
Figure 4. Nuclear Imaging (PET & SPECT) Reagents Product Picture
Figure 5. Magnetic Resonance Imaging (MRI) Reagents Product Picture
Figure 6. Fluorescence Imaging Reagents Product Picture
Figure 7. Ultrasound and X-ray Contrast Reagents Product Picture
Figure 8. Other Product Picture
Figure 9. Global Biologic and Medical Imaging Reagents Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application in 2024 & 2031
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Other
Figure 14. Biologic and Medical Imaging Reagents Report Years Considered
Figure 15. Global Biologic and Medical Imaging Reagents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biologic and Medical Imaging Reagents Market Size (2020-2031) & (US$ Million)
Figure 17. Global Biologic and Medical Imaging Reagents Market Size Market Share by Region: 2024 Versus 2031
Figure 18. Global Biologic and Medical Imaging Reagents Revenue Market Share by Region (2020-2031)
Figure 19. Global Biologic and Medical Imaging Reagents Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Global Biologic and Medical Imaging Reagents Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Nuclear Imaging (PET & SPECT) Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application, 2024 VS 2031
Figure 22. Magnetic Resonance Imaging (MRI) Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application, 2024 VS 2031
Figure 23. Fluorescence Imaging Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application, 2024 VS 2031
Figure 24. Ultrasound and X-ray Contrast Reagents of Biologic and Medical Imaging Reagents Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Biologic and Medical Imaging Reagents Revenue Market Share by Application, 2024 VS 2031
Figure 26. Biologic and Medical Imaging Reagents Revenue Share by Company (2024)
Figure 27. Biologic and Medical Imaging Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Nuclear Imaging (PET & SPECT) Reagents Revenue Proportion by Company in 2024
Figure 29. Magnetic Resonance Imaging (MRI) Reagents Revenue Proportion by Company in 2024
Figure 30. Fluorescence Imaging Reagents Revenue Proportion by Company in 2024
Figure 31. Ultrasound and X-ray Contrast Reagents Revenue Proportion by Company in 2024
Figure 32. Other Revenue Proportion by Company in 2024
Figure 33. North America Biologic and Medical Imaging Reagents Revenue 2020-2031 (US$ Million)
Figure 34. North America Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2025)
Figure 35. North America Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2025)
Figure 36. Asia-Pacific Biologic and Medical Imaging Reagents Revenue 2020-2031 (US$ Million)
Figure 37. Asia-Pacific Biologic and Medical Imaging Reagents Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2025)
Figure 40. Europe Biologic and Medical Imaging Reagents Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Biologic and Medical Imaging Reagents Revenue Market Share by Country (2020-2031)
Figure 42. Europe Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2025)
Figure 43. Europe Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2025)
Figure 44. Latin America Biologic and Medical Imaging Reagents Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Biologic and Medical Imaging Reagents Revenue Market Share by Country (2020-2031)
Figure 46. Latin America Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2025)
Figure 47. Latin America Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2025)
Figure 48. Middle East and Africa Biologic and Medical Imaging Reagents Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Middle East and Africa Biologic and Medical Imaging Reagents Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Biologic and Medical Imaging Reagents Revenue Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Biologic and Medical Imaging Reagents Revenue Market Share by Application (2020-2025)
Figure 52. Biologic and Medical Imaging Reagents Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Biologic and Medical Imaging Reagents Raw Materials by Region in 2024
Figure 54. Biologic and Medical Imaging Reagents Distribution Channels
Figure 55. Global Biologic and Medical Imaging Reagents Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Biologic and Medical Imaging Reagents Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Our Clients